The Summary
In a randomized, placebo-controlled trial, researchers evaluated 22 adults with metabolic syndrome who completed a five-week supervised aerobic training program while taking either metformin (1000 mg/day) or a placebo. The metformin group experienced significantly greater increases in maximal fat oxidation and overall energy expenditure during moderate workouts. However, their absolute cardiorespiratory fitness gains (VO2peak) were modestly blunted compared to the placebo group. Additionally, metformin users reported higher perceived physical exertion during exercise, and older participants taking the drug showed the least cardiovascular improvement.
Why this is interesting
Metformin and exercise are routinely paired to treat metabolic dysfunction, with the assumption they work perfectly together. This study reveals a surprising clash: while metformin helper-boosts fat burning, it actually hinders cardiovascular fitness adaptations and makes workouts feel harder, especially as we age. This challenges the one-size-fits-all approach to metabolic health. For readers, it emphasizes that if you are taking metformin, your cardio progress might feel slower and more difficult, signaling a need for highly personalized exercise prescription and medical guidance.